Alkem Laboratories Limited
ALKEM
Rang in Aktien
#2830
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Aktienkurs
$55.22
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$6.60B
Veränderung (1 Tag)
-1.29%
Veränderung (1 Jahr)
-12.67%
Land
IN
Handel Alkem Laboratories Limited (ALKEM)
Kategorie
Healthcare
EPS für Alkem Laboratories Limited (ALKEM)
EPS zum June 2026 TTM: $1.99
Laut den aktuellen Finanzberichten und dem Aktienkurs von Alkem Laboratories Limited beträgt das aktuelle EPS des Unternehmens (TTM) $1.99. Am Ende des Jahres 2024 betrug das EPS $1.80 eine Steigerung gegenüber dem EPS von 2023, das $1.00 betrug.
EPS-Verlauf von Alkem Laboratories Limited von 2010 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $1.99 | -6.17% |
| 2025 | $2.12 | 17.57% |
| 2024 | $1.80 | 79.83% |
| 2023 | $1.00 | -44.76% |
| 2022 | $1.81 | 0.12% |
| 2021 | $1.81 | 44.74% |
| 2020 | $1.25 | 36.59% |
| 2019 | $0.92 | 13.02% |
| 2018 | $0.81 | -29.55% |
| 2017 | $1.15 | 22.89% |
| 2016 | $0.94 | 78.39% |
| 2015 | $0.52 | -14.30% |
| 2014 | $0.61 | -19.80% |
| 2013 | $0.76 | 8.82% |
| 2012 | $0.70 | 15.60% |
| 2011 | $0.61 | 38.68% |
| 2010 | $0.44 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -72.03% |
IN
|
